Trial Profile
Phase III trial of intravenous Hep-114 in patients with toxic liver damage
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 06 Apr 2015
Price :
$35
*
At a glance
- Drugs Hep 114 (Primary)
- Indications Liver injury
- Focus Registrational; Therapeutic Use
- 06 Apr 2015 New trial record